25% (oral)

Class B (NZ), Schedule I and III (US)

Class C (UK)

Schedule III (Canada)

S9 (Australia)

Usually oral; intravenous

95%, mainly Hepatic, also in blood and tissues

5%, renal

30–60 minutes

B